-
公开(公告)号:US5552429A
公开(公告)日:1996-09-03
申请号:US442733
申请日:1995-05-17
申请人: David T. Wong , Juan I. Oguiza
发明人: David T. Wong , Juan I. Oguiza
IPC分类号: A61K31/445 , A61K31/13 , A61K31/135 , A61K31/138 , A61K31/38 , A61K31/395 , A61K31/40 , A61K31/41 , A61K31/435 , A61K31/475 , A61K31/495 , A61K31/535 , A61K31/54 , A61K31/55 , A61K45/06 , A61P9/12
CPC分类号: A61K45/06 , A61K31/135 , A61K31/38 , A61K31/40
摘要: The power of fluoxetine, venlafaxine, milnacipran and duloxetine to increase the availability of serotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination with a drug which is a serotonin 1A receptor antagonist.
-
公开(公告)号:US5532268A
公开(公告)日:1996-07-02
申请号:US442735
申请日:1995-05-17
申请人: David T. Wong , Juan I. Oguiza
发明人: David T. Wong , Juan I. Oguiza
IPC分类号: A61K31/445 , A61K31/13 , A61K31/135 , A61K31/138 , A61K31/38 , A61K31/395 , A61K31/40 , A61K31/41 , A61K31/435 , A61K31/475 , A61K31/495 , A61K31/535 , A61K31/54 , A61K31/55 , A61K45/06 , A61P9/12
CPC分类号: A61K45/06 , A61K31/135 , A61K31/38 , A61K31/40
摘要: The power of fluoxetine, venlafaxine, milnacipran and duloxetine to increase the availability of serotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination with a drug which is a serotonin 1A receptor antagonist.
-
公开(公告)号:US5532264A
公开(公告)日:1996-07-02
申请号:US442736
申请日:1995-05-17
申请人: David T. Wong , Juan I. Oguiza
发明人: David T. Wong , Juan I. Oguiza
IPC分类号: A61K31/445 , A61K31/13 , A61K31/135 , A61K31/138 , A61K31/38 , A61K31/395 , A61K31/40 , A61K31/41 , A61K31/435 , A61K31/475 , A61K31/495 , A61K31/535 , A61K31/54 , A61K31/55 , A61K45/06 , A61P9/12 , A61K31/165
CPC分类号: A61K45/06 , A61K31/135 , A61K31/38 , A61K31/40
摘要: The power of fluoxetine, venlafaxine, milnacipran and duloxetine to increase the availability of serotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination with a drug which is a serotonin 1A receptor antagonist.
-
公开(公告)号:US5532244A
公开(公告)日:1996-07-02
申请号:US442737
申请日:1995-05-17
申请人: David T. Wong , Juan I. Oguiza
发明人: David T. Wong , Juan I. Oguiza
IPC分类号: A61K31/445 , A61K31/13 , A61K31/135 , A61K31/138 , A61K31/38 , A61K31/395 , A61K31/40 , A61K31/41 , A61K31/435 , A61K31/475 , A61K31/495 , A61K31/535 , A61K31/54 , A61K31/55 , A61K45/06 , A61P9/12
CPC分类号: A61K45/06 , A61K31/135 , A61K31/38 , A61K31/40
摘要: The power of fluoxetine, venlafaxine, milnacipran and duloxetine to increase the availability of serotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination with a drug which is a serotonin 1A receptor antagonist.
-
公开(公告)号:US5538992A
公开(公告)日:1996-07-23
申请号:US442734
申请日:1995-05-17
申请人: David T. Wong , Juan I. Oguiza
发明人: David T. Wong , Juan I. Oguiza
IPC分类号: A61K31/445 , A61K31/13 , A61K31/135 , A61K31/138 , A61K31/38 , A61K31/395 , A61K31/40 , A61K31/41 , A61K31/435 , A61K31/475 , A61K31/495 , A61K31/535 , A61K31/54 , A61K31/55 , A61K45/06 , A61P9/12
CPC分类号: A61K45/06 , A61K31/135 , A61K31/38 , A61K31/40
摘要: The power of fluoxetine, venlafaxine, milnacipran and duloxetine to increase the availability of serotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination with a drug which is a serotonin 1A receptor antagonist.
摘要翻译: 氟西汀,文拉法辛,米那普仑和度洛西汀增加5-羟色胺,去甲肾上腺素和多巴胺,特别是5-羟色胺的可用性的功效通过与作为血清素1A受体拮抗剂的药物组合施用而增加。
-
公开(公告)号:US5532250A
公开(公告)日:1996-07-02
申请号:US442609
申请日:1995-05-17
申请人: David T. Wong , Juan I. Oguiza
发明人: David T. Wong , Juan I. Oguiza
IPC分类号: A61K31/445 , A61K31/13 , A61K31/135 , A61K31/138 , A61K31/38 , A61K31/395 , A61K31/40 , A61K31/41 , A61K31/435 , A61K31/475 , A61K31/495 , A61K31/535 , A61K31/54 , A61K31/55 , A61K45/06 , A61P9/12
CPC分类号: A61K45/06 , A61K31/135 , A61K31/38 , A61K31/40
摘要: The power of fluoxetine, venlafaxine, milnacipran and duloxetine to increase the availability of serotonin, norepinephrine and dopamine, particularly serotonin, is augmented by administration in combination with a drug which is a serotonin 1A receptor antagonist.
-
-
-
-
-